Bausch Health Companies Inc.
NYSE: BHC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Thomas J. Appio
- Employees
- 20,700
- Headquarters
- Laval, Canada
- IPO year
- 1994
- Market cap
- $1.9B
- Website
- https://www.bauschhealth.com
Loading BHC…
Loading profile data…Frequently asked questions about BHC
What does Bausch Health Companies Inc. (BHC) do?
Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise co...
Where does BHC trade?
Bausch Health Companies Inc. (BHC) trades on the New York Stock Exchange.
What sector is BHC in?
Bausch Health Companies Inc. (BHC) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Bausch Health Companies Inc.?
Thomas J. Appio is the chief executive officer of Bausch Health Companies Inc. (BHC).
Where is Bausch Health Companies Inc. headquartered?
Bausch Health Companies Inc. is headquartered in Canada.
Does BHC pay a dividend?
Bausch Health Companies Inc. (BHC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BHC go public?
Bausch Health Companies Inc. (BHC) completed its initial public offering in 1994.